Skip to main content

Mona Fiuzat

Adjunct Associate Professor in the Department of Medicine
Medicine, Clinical Pharmacology
DUMC Box 3356, Durham, NC 27710
1530 Key Blvd, #124, Arlington, VA 22209

Scholarly Works - Conferences


A CALL TO ACTION: HOW CAN CONGRESS HELP ENHANCE DIVERSITY IN CLINICAL TRIALS?

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 2, 2024 Link to item Cite

TRAINING THE NEXT GENERATION: A NOVEL INITIATIVE FROM THE HEART FAILURE COLLABORATORY

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 2, 2024 Link to item Cite

Variation Of Prespecified Subgroups In Large-Scale HF Outcome Trials

Conference JOURNAL OF CARDIAC FAILURE · January 2024 Link to item Cite

A CALL TO ACTION: HOW CAN CONGRESS HELP ENHANCE DIVERSITY IN CLINICAL TRIALS?

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · 2024 Cite

TRAINING THE NEXT GENERATION: A NOVEL INITIATIVE FROM THE HEART FAILURE COLLABORATORY

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · 2024 Cite

Abstract 12936: Quality of Life Assessments as Inclusion Criteria in Heart Failure Clinical Trials

Conference Circulation · November 7, 2023 Background: Patient-reported quality of life (QoL) assessments, such as the Kansas City Cardiomyopathy Questionnaire (KCCQ) or Minnesota Living with Heart Failure Questionnaire (MLHFQ), reflect an ind ... Full text Cite

A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study.

Conference Circ Heart Fail · February 2023 BACKGROUND: As heart failure therapeutic care becomes increasingly complex, a composite medical therapy score could be useful to conveniently summarize background medical therapy. We applied the composite medical therapy score developed by the Heart Failur ... Full text Link to item Cite

Adjudication Of Cause-specific Endpoints In Heart Failure Trials

Conference JOURNAL OF CARDIAC FAILURE · October 2020 Link to item Cite

Heart Failure Society of America Research Network Survey

Conference Journal of Cardiac Failure · August 2018 Full text Cite

A Multi-Marker Approach for Risk Stratification in Patients With Chronic Heart Failure: Insights From the HF-ACTION Trial

Conference · 2017 Introduction: It is unclear whether multi-marker approaches improve risk stratification among patients with heart failure (HF). We evaluated the prognostic utility of a multi-marker approach with biomarkers of HF status; Growth-differentiation factor-15 (G ... Cite

Cardiovascular Improvements With Adaptive Servo-Ventilation In Heart Failure: Insights From The Cat-Hf Trial

Conference AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE · January 1, 2016 Link to item Cite

Diuretic response in acute heart failure: clinical characteristics and prognostic significance.

Conference Eur Heart J · May 14, 2014 AIM: Diminished diuretic response is common in patients with acute heart failure, although a clinically useful definition is lacking. Our aim was to investigate a practical, workable metric for diuretic response, examine associated patient characteristics ... Full text Link to item Cite

SOCIOECONOMIC STATUS, MARITAL STATUS AND OUTCOMES IN HEART FAILURE: FINDINGS FROM HF-ACTION

Conference Journal of the American College of Cardiology · April 2014 Full text Cite

QUALITY OF LIFE 60 DAYS AFTER AN ACUTE HEART FAILURE EVENT: INSIGHTS FROM THE PROTECT TRIAL

Conference Journal of the American College of Cardiology · March 2012 Full text Cite

HYPONATREMIA AND LONG-TERM OUTCOMES IN HEART FAILURE

Conference Journal of the American College of Cardiology · April 2011 Full text Cite

HAS THE US STOCK MARKET COLLAPSE IMPACTED CARDIOVASCULAR EVENT RATES?

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 9, 2010 Link to item Cite

IMPACT OF BASELINE VOLUME STATUS AND LVEF ON ALL-CAUSE MORTALITY IN THE BEST TRIAL

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 9, 2010 Link to item Cite